PL2081952T3 - Peptydy - Google Patents

Peptydy

Info

Publication number
PL2081952T3
PL2081952T3 PL07823917T PL07823917T PL2081952T3 PL 2081952 T3 PL2081952 T3 PL 2081952T3 PL 07823917 T PL07823917 T PL 07823917T PL 07823917 T PL07823917 T PL 07823917T PL 2081952 T3 PL2081952 T3 PL 2081952T3
Authority
PL
Poland
Prior art keywords
peptides
Prior art date
Application number
PL07823917T
Other languages
English (en)
Inventor
Roger New
Original Assignee
Lexcicon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0618512.8A external-priority patent/GB0618512D0/en
Priority claimed from GB0707626A external-priority patent/GB0707626D0/en
Application filed by Lexcicon Ltd filed Critical Lexcicon Ltd
Publication of PL2081952T3 publication Critical patent/PL2081952T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
PL07823917T 2006-09-20 2007-09-20 Peptydy PL2081952T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0618512.8A GB0618512D0 (en) 2006-09-20 2006-09-20 Peptides
GB0707626A GB0707626D0 (en) 2007-04-19 2007-04-19 Peptides
EP07823917.5A EP2081952B1 (en) 2006-09-20 2007-09-20 Peptides
PCT/GB2007/003592 WO2008035093A2 (en) 2006-09-20 2007-09-20 Peptides

Publications (1)

Publication Number Publication Date
PL2081952T3 true PL2081952T3 (pl) 2014-07-31

Family

ID=39048085

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07823917T PL2081952T3 (pl) 2006-09-20 2007-09-20 Peptydy

Country Status (16)

Country Link
US (2) US9096650B2 (pl)
EP (1) EP2081952B1 (pl)
JP (1) JP5475451B2 (pl)
KR (1) KR20090079199A (pl)
AU (1) AU2007298717B2 (pl)
BR (1) BRPI0716891A2 (pl)
CA (1) CA2664064A1 (pl)
CY (1) CY1115097T1 (pl)
DK (1) DK2081952T3 (pl)
ES (1) ES2459020T3 (pl)
IL (1) IL197675A (pl)
PL (1) PL2081952T3 (pl)
PT (1) PT2081952E (pl)
RU (1) RU2496789C2 (pl)
SI (1) SI2081952T1 (pl)
WO (1) WO2008035093A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6754997B2 (ja) 2013-08-26 2020-09-16 国立大学法人 東京大学 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法
WO2016169894A1 (en) 2015-04-20 2016-10-27 F. Hoffmann-La Roche Ag Specific peptide binders to proteins identified via systemic discovery, maturation and extension process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000143698A (ja) * 1998-11-12 2000-05-26 Japan Science & Technology Corp グラミシジン類縁体環状ペプチド及びそれを用いた親油性有機化合物の補捉剤
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
WO2006043933A1 (en) * 2004-10-15 2006-04-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serine protease inhibitors

Also Published As

Publication number Publication date
US20100022448A1 (en) 2010-01-28
PT2081952E (pt) 2014-04-30
AU2007298717B2 (en) 2013-05-02
WO2008035093A2 (en) 2008-03-27
SI2081952T1 (sl) 2014-05-30
JP5475451B2 (ja) 2014-04-16
BRPI0716891A2 (pt) 2013-10-22
RU2496789C2 (ru) 2013-10-27
WO2008035093A3 (en) 2008-10-02
CA2664064A1 (en) 2008-03-27
ES2459020T3 (es) 2014-05-07
EP2081952B1 (en) 2014-01-22
AU2007298717A1 (en) 2008-03-27
RU2009114708A (ru) 2010-10-27
IL197675A (en) 2014-06-30
US9096650B2 (en) 2015-08-04
KR20090079199A (ko) 2009-07-21
CY1115097T1 (el) 2016-12-14
IL197675A0 (en) 2009-12-24
US20150307557A1 (en) 2015-10-29
DK2081952T3 (da) 2014-04-28
JP2010504313A (ja) 2010-02-12
EP2081952A2 (en) 2009-07-29

Similar Documents

Publication Publication Date Title
ZA200810738B (en) Polypeptide
DE602007008470D1 (en) Off
IL192960A0 (en) Heteroaroyl-substituted alanines
EP2017283A4 (en) Peptides
EP2021364A4 (en) IMPROVED ANTIMICROBIAL PEPTIDES
GB0723712D0 (en) Peptides
GB0611116D0 (en) Proteins
EP2123666A4 (en) PEPTIDE
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
EP2036918A4 (en) PEPTIDE DERIVATIVE
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
GB0703945D0 (en) Peptide
GB0609121D0 (en) Peptide Therapy
GB0713585D0 (en) Equivalent
GB0618748D0 (en) Peptide
IL197675A0 (en) Peptides
GB0623539D0 (en) Polypeptides
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0605774D0 (en) Peptide
GB0612623D0 (en) Proteins
GB0612443D0 (en) Protein
GB0618512D0 (en) Peptides